Andrew Brackbill is an experienced professional in market access and pricing strategy, currently serving as the Director of Market Access Contract Strategy for Specialty Products at Pfizer since 2023. Prior to this role, Andrew held several positions at Johnson & Johnson, including Director of Global Pricing Strategy and Director of US Channel Strategy, contributing to oncology and complex therapies. With a background in finance from Wyeth Pharmaceuticals and a comprehensive education, including an MBA in Marketing and a certificate in Health Policy, Andrew has developed a robust skill set in pharmaceutical pricing and reimbursement strategies.
This person is not in any teams
This person is not in any offices